ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising

AUROPHARMA NEWS reasons for why stock price of Aurobindo Pharma Limited is falling or rising

AUROPHARMA Aurobindo Pharma is falling or rising technical reasons

Technical analysis forecast of Aurobindo Pharma Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Aurobindo Pharma AUROPHARMA at this time. Stock is rising and might rise more.

It appears as if Aurobindo Pharma AUROPHARMA gave a large move recently.

Stock of Aurobindo Pharma (AUROPHARMA) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

Although my analysis for Aurobindo Pharma is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 1529.4, for a target of 1492.3 or 1461.32

AUROPHARMA Aurobindo Pharma is falling or rising NEWS fundamental reasons

Company Announcement Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 22, 2026, titled "Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company". - NEWS as on 2026-06-22

Company Announcement Aurobindo Pharma Limited has informed the Exchange about General Updates - NEWS as on 2026-06-22

Aurobindo Pharma US gets FTC nod for 0 million acquisition of Lannett Company Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its 0 million acquisition of Lannett Company. This strategic move, expected to conclude by June 2026, will bolster Aurobindo's complex generics and controlled substances portfol - NEWS as on 2026-06-22 indiatimes.com

Company Announcement Aurobindo Pharma Limited has informed that the necessary approval from US Federal Trade Commission (FTC) for the acquisition of the Lannett business has been obtained today. - NEWS as on 2026-06-19

Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federal Trade Commission for its takeover of Lannett Company. This regulatory approval removes the final hurdle. The acquis - NEWS as on 2026-06-19 indiatimes.com

Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 more Quant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and four more. The fund also added six new stocks, exited three positions and maintained a defensive tilt through a highe - NEWS as on 2026-06-12 indiatimes.com

Company Announcement Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2026-06-11

Company Announcement Aurobindo Pharma Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-06-09

Company Announcement - NEWS as on 2026-06-05

Company Announcement Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Aurobindo Pharma Inaugurates TheraNym - Pioneering India s Large-Scale Biologics Contract Manufacturing Facility". - NEWS as on 2026-06-04

Company Announcement Aurobindo Pharma Limited has informed the Exchange about Transcript - NEWS as on 2026-05-29

More announcements and NEWS

AUROPHARMA Aurobindo Pharma Limited current price & indicator signals

Moving Averages for Aurobindo Pharma Limited

  • 5Day Average: 1478
  • 12Day Average: 1457.19
  • 20Day Average: 1451.95
  • 50Day Average: 1445.5
  • 100Day Average: 1338.56
  • 150Day Average: 1291.86
  • 200Day Average: 1243.84

AUROPHARMA Indicators & signals

Indicator MACD (12,26,9)

1467.71, 1456.87, 4.5
Indicator MACD is in positive zone

Indicator ADX (14)

27.71, 31.17, 17.64
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AUROPHARMA Aurobindo Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
23 Tue Jun 2026 1534.20 1492.20 to 1542.70 2.84% 1.47 times
22 Mon Jun 2026 1491.90 1476.50 to 1511.00 -0.39% 1.21 times
19 Fri Jun 2026 1497.80 1446.40 to 1503.10 3.75% 1.76 times
18 Thu Jun 2026 1443.70 1416.10 to 1447.70 1.5% 0.66 times
17 Wed Jun 2026 1422.40 1400.00 to 1434.10 1.84% 0.77 times
16 Tue Jun 2026 1396.70 1391.30 to 1410.00 -0.82% 0.78 times
15 Mon Jun 2026 1408.30 1391.00 to 1469.40 -4.38% 2.23 times
12 Fri Jun 2026 1472.80 1462.50 to 1481.00 0.59% 0.47 times
11 Thu Jun 2026 1464.10 1457.10 to 1473.70 0.72% 0.44 times
10 Wed Jun 2026 1453.60 1437.10 to 1468.40 0.32% 0.79 times
09 Tue Jun 2026 1449.00 1438.00 to 1469.00 -0.19% 0.89 times
08 Mon Jun 2026 1451.80 1445.90 to 1478.50 -0.72% 0.36 times

Videos related to: AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising

 

Back to top